Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders.

Published in: Archives of gynecology and obstetrics (2022)

Adjuvant letrozole co-administration in intra-cytoplasmic sperm injection cycles following GnRH antagonist protocol appears to improve implantation, clinical pregnancy and live birth delivery rates in women with POSEIDON group 3 expected poor ovarian response.

Keyphrases

polycystic ovary syndrome
early stage
early breast cancer
pregnancy outcomes
preterm birth
type diabetes
pregnant women
insulin resistance
ultrasound guided
combination therapy
skeletal muscle
replacement therapy
glycemic control